Please
see below for an announcement regarding requests for applications via a
Letter of Intent (LOI) for an Innovation Award from the Juvenile Diabetes
Research Foundation (JDRF) Australia. Applications close Friday 22
July at
5pm.
The LOI will be reviewed by an independent panel of experts. Shortlisted applicants will be notified in late August and invited to submit a full application in October.
What
is the Innovation Award?
The
Innovation Award is open to the best and brightest researchers, regardless of
whether they are currently in the field of type 1 diabetes research or
completely new to it. JDRF Australia are seeking innovative proposals
describing cutting-edge innovation falling outside current type 1 diabetes
research paradigms supported by collaborative teams.
This
award provides project funding of up to $1.5M for a period of two to
three years.
What does innovation look like to JDRF Australia?
Innovation is:
What does innovation look like to JDRF Australia?
Innovation is:
- the generation of a novel idea;
- extending existing knowledge into a
new and distinct area or application;
- the novel use of research tools or
technologies; and/or
- the novel use of clinical tools,
therapies, or strategies;
that
addresses a critical barrier and/or will accelerate progress towards
preventing, treating or curing type 1 diabetes.
More information is available at: http://www.t1dcrn.org.au/for-researchers/for-researchers---innovation-award-request-for-applications
MRO
Process
Compliance
checking by the MRO is not required for this first LOI application - this will
be conducted on applications that are invited to apply for the full submission
in October. However, applicants should still send the MRO a copy of the final
LOI application and a signed coversheet upon submission to JDRF
(please send to mhs@monash.edu).
Queries
about the scheme should be directed to the Medical & Health Sciences (MHS)
Team at MRO (mhs@monash.edu).
Juvenile
Diabetes Research Foundation Australia (JDRF) has published a Request for
Applications (RFA) for an Innovation Award to be administered through the Type
1 Diabetes Clinical Research Network. Applications will close at 5.00pm AEST on
Friday, 22 July 2016.
Please
refer to the Australian Type 1 Diabetes Clinical Research Network website
for further information. All queries regarding the Request for Applications
should be directed to JDRF.
Funding
for this programme is provided through the ARC’s Special Research Initiative for Type 1 Diabetes.
No comments:
Post a Comment